Ipratropium Bromide
Product Images NDC 53217-008

5 FDA label images from Aidarex Pharmaceuticals Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide (NDC 53217-008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ipratropium Inh For Ritedose 1)

Chemical Structure (Ipratropium Inh For Ritedose 1)
Chemical structure diagram of the active ingredient ipratropium bromide, showing its molecular configuration with associated bromide and water molecules.*
FDA Label Image

Figure 1 (Ipratropium Inh For Ritedose 2)

Figure 1 (Ipratropium Inh For Ritedose 2)
An instructional diagram showing a close-up of a finger applying or holding a bandage or patch on a thumb. The illustration is labeled as Figure 1 and appears to demonstrate a step in using or applying a medication device or product.*
FDA Label Image

Figure 2 (Ipratropium Inh For Ritedose 3)

Figure 2 (Ipratropium Inh For Ritedose 3)
An instructional diagram labeled 'Figure 2' showing a hand operating a device by pulling or pushing a component horizontally, indicated by two bidirectional arrows. The image likely demonstrates a step for using or assembling a device related to Ipratropium Bromide.*
FDA Label Image

Figure 3 (Ipratropium Inh For Ritedose 4)

Figure 3 (Ipratropium Inh For Ritedose 4)
An instructional illustration depicting a person using an inhaler. The image shows a side profile of the person's face with the inhaler mouthpiece positioned near the lips, demonstrating the proper technique for inhalation.*
FDA Label Image

Image Label (Ipratropium Inh For Ritedose 5)

Image Label (Ipratropium Inh For Ritedose 5)
Ipratropium Bromide inhalation solution 0.02%, 60 per box, packaged and distributed by Aidarex Pharmaceuticals LLC. The label states the active ingredient concentration as 0.5mg/2.5mL of ipratropium bromide and includes the NDC 53217-0008-01. It is a generic for Atrovent, manufactured by The Ritedose Corporation in Columbia, SC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.